
How has MusclePharm's stock price performed in 2022?
MusclePharm's stock was trading at $0.40 at the beginning of the year. Since then, MSLP shares have decreased by 56.8% and is now trading at $0.172...
Are investors shorting MusclePharm?
MusclePharm saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 5,600 shares, a decline of 4...
When is MusclePharm's next earnings date?
MusclePharm is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for MusclePha...
How were MusclePharm's earnings last quarter?
MusclePharm Co. (OTCMKTS:MSLP) issued its quarterly earnings results on Monday, May, 16th. The company reported ($0.19) earnings per share for the...
What guidance has MusclePharm issued on next quarter's earnings?
MusclePharm issued an update on its FY 2021 earnings guidance on Friday, April, 8th. The company provided earnings per share (EPS) guidance of for...
Who are MusclePharm's key executives?
MusclePharm's management team includes the following people: Mr. Ryan Charles Drexler , Exec. Chairman & CEO (Age 51, Pay $1.64M) Ms. Sabina Riz...
Who are some of MusclePharm's key competitors?
Some companies that are related to MusclePharm include CURE Pharmaceutical (CURR) , Reviva Pharmaceuticals (RVPH) , Aeterna Zentaris (AEZS) , I...
What other stocks do shareholders of MusclePharm own?
Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DAL...
What is MusclePharm's stock symbol?
MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."
About MusclePharm
MusclePharm (OTCMKTS:MSLP) Frequently Asked Questions
MusclePharm Corp. engages in the development, manufacture, and distribution of branded sports nutrition products and nutritional supplements. It offers a broad range of performance powders, capsules, tablets, and gels that satisfy the needs of enthusiasts and professionals alike. It focuses on MusclePharm and FitMiss brands.
What is the name of the company that makes sports nutrition products?
MusclePharm's stock was trading at $0.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MSLP stock has increased by 125.0% and is now trading at $0.4050. View which stocks have been most impacted by COVID-19.
What is the purpose of MusclePharm?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of powders, capsules, tablets, and gels. Its MusclePharm brand product portfolio include combat protein powder and combat crunch protein bars;
Where is Musclepharm located?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of powders, capsules, tablets, and gels. Its MusclePharm brand product portfolio include combat protein powder and combat crunch protein bars; essentials supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products; and non-genetically modified organism sports performance products with organic ingredients, plant-based proteins, and natural caffeine sources for use in the various stages of the workout. The company also provides FitMiss branded sports nutrition products, which are designed and formulated primarily for women lifestyle to cover various needs, including weight management, lean muscle mass, body composition, and general health and wellness; and On-the-Go portfolio of ready to eat products, such as combat crunch, protein crisp, organic protein, and protein cookie. MusclePharm Corporation sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports persons. The company was incorporated in 2006 and is headquartered in Calabasas, California.
Signals & Forecast
The company was incorporated in 2006 and is headquartered in Calabasas, California.
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The MusclePharm Corporation stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.41 and $0.41.
Is MusclePharm Corporation stock A Buy?
MusclePharm Corporation finds support from accumulated volume at $0.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are very negative
MusclePharm Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
About MusclePharm Corporation
In the last 100 trades there were 27.09 million shares bought and 1.28 million shares sold. The last trade was done 865 days ago by White Winston Select Asset Fund Series Fund Mp-18, Llc who bough 626.83 thousand shares.
Golden Star Signal
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of powders, capsules, tablets, and gels.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
